e-Article
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)
Document Type
Article
Author
Source
In: Journal of Neurology . (Journal of Neurology, May 2023, 270(5):2531-2546)
Subject
Language
English
ISSN
14321459
03405354
03405354